Home 2023

Hematologic and lymphatic cancer

StockWatch: For Genome Editing, Inflection Points Crowd the Calendar
GEN Edge

StockWatch: For Genome Editing, Inflection Points Crowd the Calendar

Alex Philippidis -
0
Redefining Hyperdiploid Leukemia
Cancer

Redefining Hyperdiploid Leukemia

Christina Jackson -
0
Pancreatic Tumors May Respond to Bone Marrow Cancer Drug
Cancer

Pancreatic Tumors May Respond to Bone Marrow Cancer Drug

Uduak Thomas -
0
Base Editing Tweaks HSC Epitopes for Targeted Immunotherapy
Cancer

Base Editing Tweaks HSC Epitopes for Targeted Immunotherapy

Jonathan D Grinstein, PhD -
0
New Therapeutic Approach Rewires Death Pathways to Jumpstart Apoptosis
Cancer

New Therapeutic Approach Rewires Death Pathways to Jumpstart Apoptosis

Uduak Thomas -
0
Vaccine Boosts CAR T Cell Therapy for Solid Tumors
Cancer

Vaccine Boosts CAR T Cell Therapy for Solid Tumors

Sophia Ktori -
0
Solid Strategies for CAR T-Cell Immunotherapies
Cancer

Solid Strategies for CAR T-Cell Immunotherapies

Kathy Vuksanaj -
0
Tissue-Mimicking Biomaterials Engineered to Steer T-Cell Development
Cancer

Tissue-Mimicking Biomaterials Engineered to Steer T-Cell Development

Julianna LeMieux, PhD -
1
Stem Cells and Reprogramming in Human Acute Leukemia
Cancer

Stem Cells and Reprogramming in Human Acute Leukemia

Kathy Vuksanaj -
21
Force of Nature: Caribou Biosciences Hits Clinical Runway with CRISPR-based Cancer Therapeutics
Cancer

Force of Nature: Caribou Biosciences Hits Clinical Runway with CRISPR-based Cancer Therapeutics

Jonathan D Grinstein, PhD -
21
123...89Page 1 of 89
Copyright © 2023 Genetic Engineering & Biotechnology News. All Rights Reserved.